Skip to content

Comparison of Pruritus Incidence After Intrathecal Morphine 0.1 vs 0.2 mg in Cesarean Section

Comparison of Pruritus Incidence After Intrathecal Morphine 0.1 and 0.2 Milligrams in Cesarean Section: A Randomized Clinical Trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07054775
Enrollment
69
Registered
2025-07-08
Start date
2025-06-01
Completion date
2025-11-30
Last updated
2025-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pruritus Caused by Drug

Brief summary

This study compares the incidence of pruritus (itching) requiring treatment between two doses of intrathecal morphine (0.1 mg vs 0.2 mg) when used for spinal anesthesia during cesarean section. The study aims to determine if the lower dose (0.1 mg) can reduce pruritus incidence while maintaining adequate pain relief.

Detailed description

Spinal anesthesia is a standard technique for cesarean section. Intrathecal morphine (ITM) provides prolonged and effective analgesia but may cause adverse events including pruritus, nausea, vomiting, and respiratory depression. Current practice at Srinagarind Hospital uses ITM 0.2 mg for spinal anesthesia in cesarean section. This study investigates whether reducing the ITM dose to 0.1 mg can decrease pruritus incidence while preserving analgesic effectiveness.

Interventions

DRUGMorphine Sulfate

intrathecal administered morphine

Sponsors

Khon Kaen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

They are unaware of type of drug administered.

Intervention model description

Arm 1: intrathecal morphine (ITM) 0.1 mg Arm 2 intrathecal morphine (ITM) 0.2 mg

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

• Pregnant women aged 18-45 years * Full-term pregnancy * Scheduled for non-emergency cesarean section * ASA physical status I-III * Non-complicated pregnancy

Exclusion criteria

* Contraindication to spinal anesthesia or study drugs * Refusal to participate in the study * BMI ≥ 40 kg/m² * History of systemic skin disease or current itchy skin condition * Use of antihistamines or anti-pruritic medications within 3 days prior to surgery

Design outcomes

Primary

MeasureTime frameDescription
Incidence of pruritus requiring treatment [Time Frame: 24 hours post-operatively]24 hours* Percentage of participants requiring treatment for pruritus within 24 hours after spinal anesthesia * Measured using numerical rating scale (0-10), with treatment indicated for score ≥4 * Percentage of participants requiring treatment for pruritus within 24 hours after spinal anesthesia * Measured using numerical rating scale (0-10), with treatment indicated for score ≥4 * Percentage of participants requiring treatment for pruritus within 24 hours after spinal anesthesia * Measured using numerical rating scale (0-10), with treatment indicated for score ≥4

Countries

Thailand

Contacts

Primary ContactThepakorn Sathitkarnbmanee
thepakorns@gmail.com66-81-9547622
Backup ContactSirirat Tribuddharat
sirirat.tribuddharat@gmail.com66-81-6205920

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026